Stay updated with breaking news from Lance Turtle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists have reacted to a recent interview in which Pascal Soriot, the executive director and chief executive officer of AstraZeneca, commented on the ability of the AstraZeneca COVID-19 vaccine to induce long-lasting T-cell responses.
Just 67million doses of AZ have been distributed across the continent compared to 440m doses of the Pfizer-BioNTech jab, even though more recent studies suggest the jab provides longer protection.
'In the UK, this vaccine was used to vaccinate older people, whereas in Europe initially people thought the vaccine doesn’t work in older people,' claims the…
Eight-week gap between first and second Pfizer vaccine doses ‘a sweet spot’ For the study, researchers studied the immune responses generated by the Pfizer jab (Victoria Jones/PA) An eight-week gap between the first and second doses of the Pfizer/BioNTech Covid-19 vaccine is a “sweet spot” when it comes to generating strong immune response while protecting the UK population against the Delta variant of coronavirus, scientists have said. In a new study, funded by the Department of Health and Social Care (DHSC), researchers have found that when compared to a four-week gap, a 10-week int...
'Sweet spot' of eight-week gap between Pfizer jabs Decision balances 'all the wider issues' Updated The eight-week gap between jabs has been called a 'sweet spot' Guarantee you'll never miss another big story by signing up for our free email updatesInvalid EmailSomething went wrong, please try again later. Subscribe We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time.More info Thank you for subscribingWe have more newslettersShow ...